NXTM: Summary for NxStage Medical, Inc. - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 5:11am EST - Canadian Markets open in 4 hours and 19 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Nxstage Medical, Inc. (NXTM)

On Feb 9: 7.81 USD 0.00 (0.00%)

MORE ON NXTM

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

NxStage Medical, Inc. (NGM:NXTM) Delayed quote data

Last Trade:	7.81 USD
Trade Time:	Feb 9
Change:	0.00 (0.00%)
Prev Close:	7.81
Open:	N/A
Bid:	7.48 x 200
Ask:	N/A
1y Target Est:	9.81

Day's Range:	N/A - N/A
52wk Range:	1.90 - 9.25
Volume:	0
Avg Vol (3m):	95,884.1
Market Cap:	364.70M
P/E (ttm):	N/A
EPS (ttm):	-0.96
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y

Add NXTM to Portfolio

Download Data

HEADLINES

•	NxStage(R) and Nordic Medcom Sign Distribution Agreement for the System One(TM)
	PRNewswire (Wed, Feb 3)

•	NxStage(R) CEO and Founder to Participate in Innovator's Panel Discussion at the Liquidnet Forum: How the Healthcare Market is Curing Itself
	PRNewswire (Thu, Jan 28)

•	NxStage Medical, Inc. Earnings Call scheduled for Thu, Feb 25
	CCBN (Mon, Jan 25)

•	NxStage to Report Fourth Quarter and Full Year 2009 Financial Results
	PRNewswire (Mon, Jan 25)

•	NxStage to Present at the Deutsche Bank Small and Mid Cap Conference
	PRNewswire (Fri, Jan 22)

•	NxStage(R) Announces New Vice President and General Manager, International
	PRNewswire (Tue, Jan 19)

•	Coverage initiated on Nxstage Medical by Rodman & Renshaw
	Briefing.com (Fri, Jan 8)

•	ObamaCare Using PBMs As A Solution To High Health Care Costs: Which Stocks To Benefit?
	Wall Street Transcript (Wed, Dec 16)

•	Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM)
	PRNewswire (Tue, Dec 15)

•	ThermoGenesis names health care executive to board
	AP (Thu, Dec 10)

More Headlines for NXTM...

ANALYST

EPS Est (next year) (Dec-09) :	-0.94
EPS Est (in 2 years) (Dec-10) :	-0.65
Avg Rec (current)*:	1.4
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

NxStage Medical, Inc., a medical device company, engages in the development, manufacture, and marketing of products for the treatment of kidney failure, fluid overload, and related blood treatments and procedures in the United States.

Full Company Profile

Add to Portfolio

Email to a Friend

•